ERBB2 and colonic neoplasm: To investigate the efficacy of HER2-targeted therapy in colon cancer cells harboring HER2 G776S, we examined the effect of treatment with afatinib, an irreversible pan-HER tyrosine kinase inhibitor (TKI).